SIGHT SCIENCES, INC. Accounts Receivable, Allowance for Credit Loss, Current
SIGHT SCIENCES, INC. (SGHT) had Accounts Receivable, Allowance for Credit Loss, Current of $113.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss, Current $113.00K.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss, Current $139.00K.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $234.00K.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss, Current $224.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $113.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $139.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $234.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $224.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $356.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $629.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $689.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $824.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.06M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $1.19M 10-K · filed 2025-03-07 |
| 2023-09-30 | $1.41M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.04M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $774.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.02M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |